Form 8-K - Current report:
SEC Accession No. 0001437749-17-011751
Filing Date
2017-06-23
Accepted
2017-06-23 11:21:16
Documents
1
Period of Report
2017-06-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atrn20170622_8k.htm 8-K 26584
  Complete submission text file 0001437749-17-011751.txt   28046
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51353 | Film No.: 17926830
SIC: 7389 Services-Business Services, NEC